Pharmeasy is in loss despite the growth in revenue and valuation. In the first quarter of the Fiscal 2022, the total loss was of Rs. 313 crore The loss of the company increased by 91% in Fiscal 2021. The company reported a loss of Rs. 641 crore in Fiscal 2021 which is almost two times higher compared to the loss of Fiscal 2020 which was Rs. 335 crore. The company clocked a revenue of Rs. 2360 crore in Fiscal 2021 which is three times higher than Fiscal 2020 which was Rs. 737 crore.